Contributor: Daniel Parker
This blog post was originally published in Wall Street Letter.
Industry participants that oppose the onerous and complicated requirements of Basel III may succeed in permanently eliminating a U.S. implementation. Although it is likely that enhanced capital and risk standards, as mandated by the Dodd-Frank Act (“DFA”) will be implemented, they may however, depending on certain pending initiatives, be prescribed through government and industry collaboration.
In response to a request by industry participants, the U.S. federal banking agencies, on November 9, 2012, released a joint release indefinitely delaying the January 1, 2013 U.S. implementation of Basel III.... read more
Commentary from SunGard experts on news and events affecting the financial services industry.
Contributor: SunGard Viewpoint
Q&A with Mat Newman, vice president, product management, SunGard's capital markets business
Q: In June the Federal Reserve announced what was called by some a rigorous interpretation of Basel III, the international agreement on higher capital standards for banks. What are three key points that people need to understand about this development?
A:...... read more
Gavin Lee, chief operating officer, FastVal, SunGard’s asset management business
Contributor: Gavin Lee
The concept of centrally clearing all OTC derivatives - both standardized and complex derivatives - is flawed. The current regulatory expectation for institutional investors is to go through a central clearing party for an expanded range of products. Compounding this requirement is that derivatives will need to be reported through trade repositories. This means that derivative products have to be cleared through a central counterparty, but not every derivative instrument fits this model.... read more
vice president, collateral management, SunGard's capital markets business
Contributor: Ted Allen
This blog post originally appeared on TabbFORUM.
This is the year that regulatory changes are starting to bite. Dodd-Frank, EMIR and Basel III are all combining to fuel huge growth in the demand for high-quality assets for use as collateral and to maintain liquidity levels. To add to the complexity, we are experiencing a simultaneous drop in the availability of these in-demand assets. These things together have created the infamous collateral squeeze.... read more
global head of strategy, SunGard's capital markets business
Contributor: Peter Banham
It is clear that regulatory changes are transforming the OTC derivatives space, from execution to settlement. There are many challenges at play here. As we head into 2012, market participants will need to manage large volumes of data in order to clear and process trades, and we will see new pressures on the cost and the more effective use of capital. In response to this industry transformation, my team and I have identified 10 key trends shaping OTC derivatives today.... read more